GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Asia Green Biotechnology Corp (XCNQ:ASIA) » Definitions » Price-to-Owner-Earnings

Asia Green Biotechnology (XCNQ:ASIA) Price-to-Owner-Earnings : (As of Jun. 06, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Asia Green Biotechnology Price-to-Owner-Earnings?

As of today (2024-06-06), Asia Green Biotechnology's share price is C$0.015. Asia Green Biotechnology does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Asia Green Biotechnology's Price-to-Owner-Earnings or its related term are showing as below:


XCNQ:ASIA's Price-to-Owner-Earnings is not ranked *
in the Drug Manufacturers industry.
Industry Median: 25.47
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-06), Asia Green Biotechnology's share price is C$0.015. Asia Green Biotechnology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was C$-0.01. Therefore, Asia Green Biotechnology's PE Ratio for today is At Loss.

As of today (2024-06-06), Asia Green Biotechnology's share price is C$0.015. Asia Green Biotechnology's EPS without NRI for the trailing twelve months (TTM) ended in was C$-0.01. Therefore, Asia Green Biotechnology's PE Ratio without NRI for today is At Loss.


Asia Green Biotechnology Price-to-Owner-Earnings Historical Data

The historical data trend for Asia Green Biotechnology's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asia Green Biotechnology Price-to-Owner-Earnings Chart

Asia Green Biotechnology Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - - - -

Asia Green Biotechnology Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Asia Green Biotechnology's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Asia Green Biotechnology's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asia Green Biotechnology's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Asia Green Biotechnology's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Asia Green Biotechnology's Price-to-Owner-Earnings falls into.



Asia Green Biotechnology Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Asia Green Biotechnology's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.015/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Asia Green Biotechnology  (XCNQ:ASIA) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Asia Green Biotechnology Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Asia Green Biotechnology's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Asia Green Biotechnology (XCNQ:ASIA) Business Description

Traded in Other Exchanges
N/A
Address
707 - 7th Avenue SW, Suite 1150, Calgary, AB, CAN, T2P 3H6
Asia Green Biotechnology Corp is an early stage international agri-technology company focused on the development, evaluation, testing, application and, ultimately, supply to the market of proprietary organic hybridization technology and certain products derived from that technology. The core approach of the business is centred on the planting, growth and harvesting of new and valuable strains of hemp and related crops in commercial quantities. The company is developing varieties of hemp with superior growth and production characteristics in the various environments found in the licensed territories.
Executives
Johannes Kingma Senior Officer

Asia Green Biotechnology (XCNQ:ASIA) Headlines